FDA Approves New Bristol-Myers Drug for Common Inherited Heart Disease

U.S. well being regulators authorized a tablet from Bristol-Myers Squibb Co. that’s the first to deal with folks with the commonest genetic coronary heart illness.

The Meals and Drug Administration cleared the drug on for folks exhibiting signs of the situation, which might result in blood clots, strokes and in uncommon circumstances, dying, Bristol stated Thursday.

Source link

Leave a Reply

Your email address will not be published.